Time to Viral Load Suppression and Its Predictors Among Adult Patients on Antiretro Viral Therapy in Nigist Eleni Mohammed Memorial Comprehensive Specialized Hospital, Hossana, Southern Ethiopia.
Eshetu ErjinoErmias AberaLire Lemma TirorePublished in: HIV/AIDS (Auckland, N.Z.) (2023)
The median time for viral load suppression was 9 months. Patients who had no opportunistic infection, with higher CD4 count, on WHO clinical stage-I or II, who have taken tuberculosis preventive therapy had higher hazards of viral load suppression. Careful monitoring and counseling of patients with CD4 levels lower than 200 cells/mm3 are necessary. Careful monitoring and counseling of patients in advanced WHO clinical stages, with lower CD4 count levels and with opportunistic infections is crucial. Strengthening the provision of tuberculosis preventive therapy is warranted.
Keyphrases
- end stage renal disease
- healthcare
- palliative care
- chronic kidney disease
- induced apoptosis
- sars cov
- newly diagnosed
- peritoneal dialysis
- pulmonary tuberculosis
- adverse drug
- prognostic factors
- hiv aids
- smoking cessation
- peripheral blood
- patient reported outcomes
- cell death
- signaling pathway
- cell cycle arrest
- cell therapy